dapsone has been researched along with quinazolines in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girard, PM; Saimot, AG | 1 |
| Montgomery, AB | 1 |
| Deng, BZ; Hu, YM; Kuang, MS; Liu, FA; Wang, XX; Zhu, QP | 1 |
| Kovacs, JA; Masur, H | 1 |
| Fischl, MA | 1 |
| Brown, VH; Colwell, WT; DeGraw, JI | 1 |
| Elslager, EF | 2 |
| Bayles, A; Olszewski, B; Thompson, PE | 1 |
| Kokwaro, G; Marsh, K; Mberu, E; Nduati, E; Nzila, A; Ommeh, S; Rosowsky, A | 1 |
6 review(s) available for dapsone and quinazolines
| Article | Year |
|---|---|
[Pneumocystis carinii pneumonia in HIV infection. Diagnosis, prognostic factors and curative treatment].
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Dapsone; Eflornithine; Folic Acid Antagonists; HIV Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1991 |
Recent developments in the therapy and management of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Quinazolines; Recurrence; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1988 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
New perspectives on the chemotherapy of malaria, filariasis, and leprosy.
Topics: Amodiaquine; Aniline Compounds; Antimalarials; Chloroquine; Cresols; Dapsone; Drug Resistance; Filariasis; Folic Acid Antagonists; Guanidines; Humans; Leprosy; Malaria; Phenethylamines; Plasmodium falciparum; Pyrrolidines; Quinazolines; Quinolines; Schiff Bases; Sulfones | 1974 |
Progress in malaria chemotherapy. 1. Repository antimalarial drugs.
Topics: Acridines; Animals; Antimalarials; Chemical Phenomena; Chemistry; Dapsone; Delayed-Action Preparations; Guanidines; Injections; Methanol; Mice; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Pyrimethamine; Quinazolines; Quinolines; Sulfonamides; Sulfones | 1969 |
1 trial(s) available for dapsone and quinazolines
| Article | Year |
|---|---|
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
5 other study(ies) available for dapsone and quinazolines
| Article | Year |
|---|---|
[Action of nitroquine on tissue schizonts of Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Dapsone; Female; Macaca mulatta; Malaria; Male; Plasmodium; Quinazolines; Recurrence | 1986 |
Treatment of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Methylprednisolone; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1987 |
Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines.
Topics: Anti-Bacterial Agents; Dapsone; Drug Synergism; Enterococcus faecalis; Erysipelothrix; Escherichia coli; Folic Acid Antagonists; Microbial Sensitivity Tests; Mycobacterium leprae; Propionibacterium acnes; Pseudomonas aeruginosa; Quinazolines; Salmonella; Staphylococcus | 1974 |
Antimalarial activity of 2,4-diamino-6-[(3,4-dichlorobenzyl) nitros-amino] quinazoline (CI-679 base) and CI-679 acetate. Laboratory studies in mice and rhesus monkeys.
Topics: Acetates; Aminobenzoates; Animals; Antimalarials; Dapsone; Drug Synergism; Female; Folic Acid; Haplorhini; Hydrocarbons, Halogenated; Male; Mice; Nitrosamines; Plasmodium; Quinazolines | 1970 |
In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
Topics: Animals; Antimalarials; Dapsone; Dihydropteroate Synthase; Drug Resistance; Folic Acid Antagonists; Plasmodium falciparum; Pteridines; Quinazolines; Saccharomyces cerevisiae; Tetrahydrofolate Dehydrogenase | 2004 |